ClinicalTrials.gov
public full text
Public Domain
Translating Extinction Research to Improve Pharmacotherapy for Tobacco Dependence
The purpose of this Pilot feasibility study is to find out the effect of different behavioral treatments along with different duration of a drug called varenicline, on smoking behavior and quitting smoking. Varenicline, also known as Chantix™, is an FDA-approved medication that has been shown to help people quit smoking.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study To Evaluate The Efficacy And Safety Of Varenicline Compared To Placebo For Smoking Cessation Through Reduction#875285
- Smoking Cessation Trial in Recurrent Acute Pancreatitis and Chronic Pancreatitis#979911
- Smoking Cessation Study for Patients With Schizophrenia or Schizoaffective Disorder#805707
- Varenicline for Adolescent Smoking Cessation#1058450
- A Study of the Efficacy and Safety of Varenicline in Japanese Smokers Motivated to Quit Smoking#1352930
Record · ID 1419181
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive